C. Tamalet

发表

Concentration-response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients.

Y. Yazdanpanah, N. Néant, C. Solas, 2019, The Journal of antimicrobial chemotherapy.

Acute and chronic hepatitis E in patients infected with human immunodeficiency virus

P. Colson, C. Dhiver, C. Tamalet, 2011, Journal of viral hepatitis.

Real-time laboratory surveillance of sexually-transmissible infections in Marseille University hospitals reveals rise of gonorrhoea, syphilis and human immunodeficiency virus seroconversions in 2012.

D. Raoult, A. Stein, S. Badiaga, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Evaluation of the clinical performance of the Beckman Coulter Access AbHBsII immunoassay for the detection of hepatitis B surface antibodies.

P. Colson, C. Tamalet, A. Motte, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study

C. Charpentier, B. Masquelier, J. Izopet, 2010, Antimicrobial Agents and Chemotherapy.

Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs.

P. Colson, C. Dhiver, C. Tamalet, 2000, AIDS.

Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease.

J. Chermann, C. Tamalet, J. Sampol, 1991, Research in immunology.

Effect of Zidovudine Resistance Mutations on Virologic Response to Treatment With Zidovudine or Stavudine, Each in Combination With Lamivudine and Indinavir

F. Brun-Vézinet, J. Izopet, G. Peytavin, 2002, Journal of acquired immune deficiency syndromes.

Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages

J. Fantini, H. Rochat, C. Tamalet, 1994 .

HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial

Steve Kaye, Francoise Brun-Vezinet, Rob Schuurman, 1997, The Lancet.

Comparative Assessment of Quantitative HIV Viraemia Assays

F. Brun-Vézinet, H. Agut, H. Fleury, 1992, AIDS.

Transmission of Hepatitis C Virus Between Hemodialysis Patients Sharing the Same Machine

M. Drancourt, Y. Berland, P. Brunet, 2004, Infection Control & Hospital Epidemiology.

Evaluation of self‐collected rectal swabs for the detection of bacteria responsible for sexually transmitted infections in a cohort of HIV‐1‐infected patients

D. Raoult, A. Stein, P. Colson, 2017, Journal of medical microbiology.

Detection of JC virus by polymerase chain reaction and colorimetric DNA hybridization assay

C. Tamalet, C. Zandotti, P. Micco, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

SVARAP and aSVARAP: simple tools for quantitative analysis of nucleotide and amino acid variability and primer selection for clinical microbiology

D. Raoult, P. Colson, C. Tamalet, 2006, BMC Microbiology.

Advantage of a rapid extraction method of HIV1 DNA suitable for polymerase chain reaction.

X. de Lamballerie, P. de Micco, C. Tamalet, 1995, Research in virology.

HIV-1 Infection and First Line ART Induced Differential Responses in Mitochondria from Blood Lymphocytes and Monocytes: The ANRS EP45 “Aging” Study

N. Lévy, J. Micallef, E. Jouve, 2012, PloS one.

Vaginal self-sampling as a diagnosis tool in low-income countries and potential applications for exploring the infectious causes of miscarriage.

D. Raoult, C. Sokhna, C. Tamalet, 2017, Future microbiology.

Human papillomavirus type 16‐induced skin squamous cell carcinoma located on the groin of immunocompetent patients

C. Tamalet, P. Stoebner, M. Segondy, 2014, The British journal of dermatology.

Feasibility, Acceptability, and Accuracy of Vaginal Self-Sampling for Screening Human Papillomavirus Types in Women from Rural Areas in Senegal.

D. Raoult, C. Sokhna, C. Tamalet, 2019, The American journal of tropical medicine and hygiene.

Feasibility and Acceptability of Anal Self-Sampling for Human Papillomavirus Screening in HIV-Infected Patients

A. Stein, P. Colson, C. Dhiver, 2016, Intervirology.

Distribution of human papillomavirus genotypes, assessment of HPV 16 and 18 viral load and anal related lesions in HIV positive patients: A cross‐sectional analysis

S. Brégigeon, C. Tamalet, I. Poizot-Martin, 2014, Journal of medical virology.

A Case of Undiagnosed HIV Infection in a 57-Year-Old Woman with Multiple Myeloma: Consequences on Chemotherapy Efficiency and Safety

R. Bouabdallah, C. Solas, S. Brégigeon, 2016, Case reports in oncological medicine.

HPV self‐sampling or the Pap‐smear: A randomized study among cervical screening nonattenders from lower socioeconomic groups in France

C. Tamalet, P. Halfon, H. Sancho-garnier, 2013, International journal of cancer.

Endothelial cell dysfunction in HIV infection.

C. Tamalet, C. Zandotti, I. Poizot-Martin, 1992, Journal of acquired immune deficiency syndromes.

HIV infection en route to endogenization: two cases

D. Raoult, A. Stein, E. Chabrière, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Mutations in HIV-1 gag cleavage sites and their association with protease mutations.

J. Fantini, C. Tamalet, N. Yahi, 2001, AIDS.

Cellular isoform of the prion protein PrPc in human intestinal cell lines: Genetic polymorphism at codon 129, mRNA quantification and protein detection in lipid rafts

J. Fantini, C. Tamalet, Xiao-jun Guo, 2006, Cell biology international.

Efficacy and Tolerance of HCV Treatment in HIV-HCV Coinfected Patients: The Potential Interaction of PI Treatment

C. Tamalet, I. Poizot-Martin, C. Marimoutou, 2003, HIV clinical trials.

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)

M. Ziol, C. Delaugerre, C. Katlama, 2022, AIDS Research and Therapy.

HPV type 6 and 16 co-infection in a 11-year-old girl presenting laryngeal papillomatosis.

J. Triglia, C. Tamalet, R. Nicollas, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Q fever and HIV infection.

D. Raoult, H. Dupont, C. Tamalet, 1993, AIDS.

Polymorphism and drug‐selected mutations in the reverse transcriptase gene of HIV‐2 from patients living in southeastern France

P. Colson, C. Tamalet, M. Henry, 2005, Journal of medical virology.

Relationship between HIV‐1 viral load and continued drug use in untreated infected injection drug users

D. Vlahov, M. Chesney, J. Moatti, 1999, Addiction biology.

Ledipasvir and tenofovir drug interaction in human immunodeficiency virus–hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safety

C. Solas, S. Brégigeon, C. Tamalet, 2018, British journal of clinical pharmacology.

How should chronic hepatitis B virus infection be managed in HIV-hepatitis B virus-coinfected patients not eligible for concomitant antiretroviral therapy?

Y. Yazdanpanah, C. Tamalet, M. Bourlière, 2008, AIDS.

Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus

P. Frange, C. Tamalet, S. Blanche, 2009, AIDS.

Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages

P. de Micco, J. Fantini, H. Rochat, 1994, Journal of virology.

Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment‐naïve chronically infected patient

P. Colson, C. Tamalet, R. Gérolami, 2008, Hepatology.

Broad Differences between the COBAS Ampliprep Total Nucleic Acid Isolation-COBAS TaqMan 48 Hepatitis C Virus (HCV) and COBAS HCV Monitor v2.0 Assays for Quantification of Serum HCV RNA of Non-1 Genotypes

P. Colson, C. Tamalet, A. Motte, 2006, Journal of Clinical Microbiology.

Underquantification of plasma HIV-1 RNA levels in a cohort of newly-diagnosed individuals.

P. Colson, C. Tamalet, A. Motte, 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors.

J. Fantini, G. Piéroni, C. Tamalet, 1998, Biochemical and biophysical research communications.

Steady HIV prevalence among pregnant women in Marseille, France

P. Boisse, M. Gamerre, C. Tamalet, 1994, European Journal of Epidemiology.

Impaired quantification of plasma HIV-1 RNA with a commercialized real-time PCR assay in a couple of HIV-1-infected individuals.

P. Colson, C. Solas, C. Tamalet, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.

J. Fantini, H. Rochat, C. Tamalet, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.

P. Colson, C. Solas, C. Tamalet, 2007, AIDS.

National survey of the prevalence and conditions of selection of HIV‐1 reverse transcriptase K70E mutation

V. Calvez, C. Delaugerre, S. Yerly, 2008, Journal of medical virology.

Production of HIV-1 by resting memory T lymphocytes

I. Hirsch, C. Tamalet, A. Biancotto, 2001, AIDS.

A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.

F. Rey, José, B. Spire, 1998, The Journal of general virology.

Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient.

P. Poignard, B. Spire, C. Tamalet, 1998, Transplantation.

Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.

P. de Micco, C. Tamalet, P. Pellegrino, 1994, Journal of acquired immune deficiency syndromes.

TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load.

P. Gallian, P. de Micco, Y. Berland, 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy

H. Richet, C. Tamalet, M. Henry, 2006, Journal of medical virology.

Specific Interaction of HIV-1 and HIV-2 Surface Envelope Glycoproteins with Monolayers of Galactosylceramide and Ganglioside GM3*

J. Fantini, G. Piéroni, C. Tamalet, 1998, The Journal of Biological Chemistry.

Co‐expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT‐29

J. Fantini, C. Tamalet, N. Yahi, 1997, AIDS.

HIV-1-induced perturbations of glycosphingolipid metabolism are cell-specific and can be detected at early stages of HIV-1 infection.

J. Fantini, C. Tamalet, N. Yahi, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[Detection and quantification of human papillomavirus genital infections: virological, epidemiological, and clinical applications].

D. Olive, C. Tamalet, M. Henry, 2011, Medecine et maladies infectieuses.

Unusual Selection of Rta181V Hbv Mutants Cross-Resistant to Adefovir following Prolonged Lamivudine Monotherapy: Report of Two Cases

P. Colson, C. Tamalet, D. Botta, 2005, Antiviral therapy.

Hepatitis B virus reactivation in HBsAg-negative patients is associated with emergence of viral strains with mutated HBsAg and reverse transcriptase.

D. Coso, F. Barlesi, C. Chabannon, 2015, Virology.

Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudine‐resistant HBV reactivation following hepatitis B surface antigen seroconversion

P. Colson, C. Tamalet, R. Gérolami, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment.

P. Colson, C. Tamalet, D. Botta, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis B and E Co-Primary Infections in an HIV-1-Infected Patient

P. Colson, C. Tamalet, H. Tissot-Dupont, 2013, Journal of Clinical Microbiology.

Nucleotide and amino acid diversity of hepatitis B virus surface antigen in acute infections, southeastern France.

P. Colson, C. Tamalet, R. Gérolami, 2017, Clinics And Research in Hepatology and Gastroenterology.

Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg‐negative and anti‐HBc antibodies‐positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer

R. Bouabdallah, D. Coso, C. Chabannon, 2010, Journal of viral hepatitis.

Entecavir as a first‐line treatment for HBV reactivation following polychemotherapy for lymphoma

D. Coso, C. Chabannon, P. Colson, 2008, British journal of haematology.

Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers.

P. Colson, C. Tamalet, R. Gérolami, 2007, Virology.

P.040 Molecular characterization of HBV genotypes newly diagnosed in 2004 in southern France

P. Colson, C. Tamalet, R. Gérolami, 2006 .

Detection of a newly identified hepatitis B virus genotype in southeastern France.

P. Colson, C. Tamalet, B. Roquelaure, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Epidemiological and virological features of HBV infection in HIV-2 infected patients living in southeastern France

P. Colson, C. Tamalet, I. Poizot-Martin, 2006, European Journal of Epidemiology.

Coexistence of the K65R/L74V and/or K65R/T215Y mutations on the same HIV-1 genome.

P. Colson, C. Tamalet, I. Poizot-Martin, 2006, Journal of Clinical Virology.

Epidemiological, clinical, virological features of hepatitis B newly diagnosed in 2011 in Marseille University hospitals, southeastern France

M. Gamerre, P. Colson, C. Tamalet, 2016, Journal of medical virology.

Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients

Y. Yazdanpanah, N. Néant, C. Solas, 2020, British journal of clinical pharmacology.

Genotypic and Phenotypic Resistance Patterns of Human Immunodeficiency Virus Type 1 Variants with Insertions or Deletions in the Reverse Transcriptase (RT): Multicenter Study of Patients Treated with RT Inhibitors

V. Calvez, F. Brun-Vézinet, B. Masquelier, 2001, Antimicrobial Agents and Chemotherapy.

Stable rearrangements of the β3–β4 hairpin loop of HIV‐1 reverse transcriptase in plasma viruses from patients receiving combination therapy

J. Fantini, J. Izopet, C. Tamalet, 1998, AIDS.

Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation.

P. Colson, Y. Berland, C. Tamalet, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine

Y. Yazdanpanah, N. Néant, C. Solas, 2018, European Journal of Clinical Pharmacology.

Antiretroviral effect of zidovudine–didanosine combination on blood and lymph nodes

J. Izopet, C. Tamalet, P. Pellegrino, 1997, AIDS.

Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency.

H. Chambost, C. Tamalet, I. Thuret, 1999, AIDS.

Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.

C. Tamalet, F. Dignat-George, I. Poizot-Martin, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Indeterminate second-generation hepatitis C recombinant immunoblot test: detection of hepatitis C virus infection by polymerase chain reaction.

C. Tamalet, P. Halfon, M. Bourlière, 1992, The Journal of infectious diseases.

Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient.

P. Colson, C. Solas, S. Brégigeon, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Transfusion-associated Hepatitis E, France

P. Gallian, P. de Micco, P. Colson, 2007, Emerging infectious diseases.

The Genotypic Inhibitory Quotient: A Predictive Factor of Atazanavir Response in HIV-1-Infected Treatment-Experienced Patients

P. Colson, C. Solas, C. Tamalet, 2008, Journal of acquired immune deficiency syndromes.

Vertical transmission of multidrug-resistant Q151M human immunodeficiency virus type 1 strains.

P. Colson, C. Solas, C. Tamalet, 2008, The Pediatric infectious disease journal.

Structural analysis of reverse transcriptase mutations at codon 215 explains the predominance of T215Y over T215F in HIV-1 variants selected under antiretroviral therapy.

J. Fantini, C. Tamalet, N. Yahi, 2005, Journal of biomedical science.

Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997–2002) based on an analysis of over 7000 genotypes

J. Fantini, C. Tamalet, N. Yahi, 2003, AIDS.

Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale.

J. Fantini, C. Tamalet, N. Yahi, 2001, The Journal of infectious diseases.

Severe Thrombocytopenia Associated with Acute Hepatitis E Virus Infection

P. Colson, C. Tamalet, L. Villeneuve, 2008, Journal of Clinical Microbiology.

353 HBV SEROLOGICAL PATTERNS IN PUBLIC HOSPITALS FROM A BIG CITY OF SOUTHERN FRANCE OVER A SEVEN-YEAR PERIOD (1998–2004)

H. Richet, P. Colson, C. Tamalet, 2009 .

P.126 Molecular characterization of HBV genotypes newly diagnosed in 2004 in southern France

P. Colson, C. Tamalet, R. Gérolami, 2006 .

Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France

P. Brouqui, A. Stein, P. Colson, 2014, Journal of medical virology.

Diversity of 1,213 hepatitis C virus NS3 protease sequences from a clinical virology laboratory database in Marseille university hospitals, southeastern France

P. Colson, S. Mokhtari, C. Tamalet, 2015, Journal of medical virology.

Emergence of hepatitis B infection despite antibodies to hepatitis B surface antigen: a new nosocomial risk in patients with end-stage renal disease.

P. Colson, Y. Berland, C. Tamalet, 2006, Transplantation.

Genomic and phylogenetic analysis of hepatitis C virus isolates: A survey of 535 strains circulating in southern France

P. Colson, C. Tamalet, I. Poizot-Martin, 2003, Journal of medical virology.

Direct effect of type 1 human immunodeficiency virus (HIV-1) on intestinal epithelial cell differentiation: relationship to HIV-1 enteropathy.

J. Fantini, C. Tamalet, S. Baghdiguian, 1997, Virology.

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease

B. Masquelier, H. Fleury, C. Rouzioux, 1996 .

HIV-1 transmission across the vaginal epithelium.

J. Fantini, C. Tamalet, N. Yahi, 1997, AIDS.

Cellular and plasma viral load in patients infected with HIV‐2

F. Brun-Vézinet, C. Dhiver, C. Tamalet, 1993, AIDS.

Kaposi's sarcoma in a treated and well-controlled HIV infected patient: Discussion on the role of immunosenescence

S. Brégigeon, C. Tamalet, C. Brunet, 2014 .

Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection.

C. Tamalet, A. Lafeuillade, C. Poggi, 1997, The Journal of infectious diseases.

Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self‐collected vaginal swabs of women who do not undergo cervical cytological screening in Southern France

H. Richet, C. Tamalet, H. Sancho-garnier, 2010, Journal of medical virology.

Resistance to human immunodeficiency virus infection: a rare but neglected state

G. Dubourg, P. Colson, C. Tamalet, 2020, Annals of the New York Academy of Sciences.

Reevaluation of possible outcomes of infections with human immunodeficiency virus.

A. Stein, E. Decroly, P. Colson, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Incidence, Persistence, Clearance, and Correlates of Genital Human Papillomavirus Infection and Anogenital Warts in a Cohort of Men Living With Human Immunodeficiency Virus in South Africa

S. Delany-Moretlwe, C. Tamalet, M. Chersich, 2019, Sexually transmitted diseases.

Comparison of viral burden and phenotype of HIV‐1 isolates from lymph nodes and blood

P. de Micco, C. Tamalet, N. Yahi, 1994, AIDS.

[Serological diagnosis of Mediterranean boutonneuse fever].

D. Raoult, P. de Micco, C. Tamalet, 1984, Pathologie-biologie.

First human cases of hepatitis E infection with genotype 3c strains.

P. Colson, C. Tamalet, R. Gérolami, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Hepatitis E associated with surgical training on pigs

P. Colson, C. Tamalet, E. Bernit, 2007, The Lancet.

Incidence, Persistence, Clearance, and Correlates of Genital Human Papillomavirus Infection and Anogenital Warts in a Cohort of Men Living With Human Immunodeficiency Virus in South Africa

S. Delany-Moretlwe, C. Tamalet, M. Chersich, 2019, Sexually transmitted diseases.

Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network

F. Brun-Vézinet, B. Masquelier, C. Rouzioux, 2007, Antiviral therapy.

Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection

C. Rouzioux, L. Meyer, C. Tamalet, 2000, AIDS.

Quantification of HIV‐1 viral load in lymphoid and blood cells: assessment during four‐drug combination therapy

J. Fantini, C. Tamalet, N. Yahi, 1997, AIDS.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France

F. Brun-Vézinet, B. Masquelier, C. Rouzioux, 2003, AIDS.

Is postexposure prophylaxis with antiretroviral therapy necessary in cases of blood exposure through a fight when HIV-1 status is unknown?

C. Tamalet, A. Chéret, A. Lafeuillade, 2014, AIDS.

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.

C. Katlama, C. Rouzioux, F. Raffi, 2015, The Lancet. Infectious diseases.

Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells.

J. Fantini, G. Piéroni, C. Tamalet, 1998, Virology.

Autologous neutralizing antibodies and viral load in HIV-2-infected individuals.

F. Brun-Vézinet, P. de Micco, C. Dhiver, 1995, AIDS.

Recombinant hepatitis C viruses that might hamper accurate genotype classification and choice of treatment with direct‐acting agents, southeastern France

P. Colson, C. Dhiver, C. Tamalet, 2016, Hepatology.

Hepatitis C Virus of Subtype 2l in Marseille, Southeastern France

L. Chiche, P. Colson, S. Brégigeon, 2015, Intervirology.

HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time

C. Rouzioux, L. Meyer, C. Tamalet, 2006, AIDS.

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2013, The Journal of antimicrobial chemotherapy.

French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002

F. Brun-Vézinet, P. André, B. Masquelier, 2005, Journal of acquired immune deficiency syndromes.

HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment.

M. Mouroux, V. Calvez, C. Rouzioux, 2000, AIDS research and human retroviruses.

Genetic analysis of hiv type 1 strains in bujumbura (burundi): predominance of subtype c variant.

J. Fantini, J. Ndihokubwayo, C. Tamalet, 2001, AIDS research and human retroviruses.

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996–2006 in France

C. Delaugerre, B. Masquelier, C. Rouzioux, 2009, AIDS.

Polymorphism and Drug-Selected Mutations in the Protease Gene of Human Immunodeficiency Virus Type 2 from Patients Living in Southern France

P. Colson, C. Tamalet, M. Henry, 2004, Journal of Clinical Microbiology.

Polymorphism and drug selected mutations of reverse transcriptase gene in 102 HIV‐1 infected patients living in China

C. Tamalet, Li Liu, M. Henry, 2007, Journal of medical virology.

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2010, The Journal of antimicrobial chemotherapy.

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group.

B. Masquelier, C. Rouzioux, D. Dormont, 1996, JAMA.

A survival method to estimate the time to occurrence of mutations: an application to thymidine analogue mutations in HIV-1-infected patients.

F. Brun-Vézinet, J. Izopet, C. Tamalet, 2004, The Journal of infectious diseases.

Predictive Factors and Selection of Thymidine Analogue Mutations by Nucleoside Reverse Transcriptase Inhibitors According to Initial Regimen Received

F. Brun-Vézinet, J. Izopet, C. Tamalet, 2003, Antiviral therapy.

Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort.

B. Masquelier, H. Fleury, C. Rouzioux, 2001 .

Mutation L210W of HIV-1 reverse transcriptase in patients receiving combination therapy. Incidence, association with other mutations, and effects on the structure of mutated reverse transcriptase.

J. Fantini, C. Tamalet, N. Yahi, 2000, Journal of biomedical science.

Mutation Patterns of the Reverse Transcriptase and Protease Genes in Human Immunodeficiency Virus Type 1-Infected Patients Undergoing Combination Therapy: Survey of 787 Sequences

J. Fantini, C. Tamalet, N. Yahi, 1999, Journal of Clinical Microbiology.

Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy

S. Brégigeon, C. Tamalet, F. Dignat-George, 2015, AIDS.

Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit

P. Carrieri, C. Solas, S. Brégigeon, 2019, European journal of gastroenterology & hepatology.

Multimorbidity in Elderly Subjects according to the year of diagnosis of HIV-Infection - A Cross-Sectional DATAIDS Cohort Study.

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Correction: HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 “Aging” Study

N. Lévy, J. Micallef, C. Solas, 2013, PLoS ONE.

Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein.

S. Spector, P. Brouqui, A. Stein, 2012, Infectious disorders drug targets.

Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Prevalent, persistent anal HPV infection and squamous intraepithelial lesions: Findings from a cohort of men living with HIV in South Africa

S. Delany-Moretlwe, P. Michelow, C. Tamalet, 2019, PloS one.

High prevalence of human T-lymphotropic virus (HTLV) infection in pregnant women in southern France

C. Tamalet, C. Zandotti, P. Micco, 1995, European Journal of Epidemiology.

Prevalence of HTLV-II in HIV-1-infected drug addicts in Marseille

C. Tamalet, C. Zandotti, J. Gastaut, 1993, European Journal of Epidemiology.

Increase in sexually transmitted infections during Europride 2013 in Marseille, France.

D. Raoult, P. Fournier, G. Dubourg, 2014, The Lancet. Infectious diseases.

Prevalence of HIV-1 Drug Resistance in Treated Patients: A French Nationwide Study

F. Brun-Vézinet, C. Delaugerre, S. Yerly, 2007, Journal of acquired immune deficiency syndromes.

Detection of the newly characterized HIV CRF56_cpx in Marseille, southeastern France.

A. Stein, P. Colson, C. Tamalet, 2014, International Journal of Infectious Diseases.

Unsupervised PrEP in routine practice: a new challenge?

C. Tamalet, I. Poizot-Martin, C. Lions, 2019, International journal of STD & AIDS.

Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutations.

J. Fantini, P. Colson, C. Dhiver, 2000, Virology.

Genotypic Determinants of the Virological Response to Tenofovir Disoproxil Fumarate in Nucleoside Reverse Transcriptase Inhibitor-Experienced Patients

F. Brun-Vézinet, B. Masquelier, D. Costagliola, 2003, Antiviral therapy.

Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV‐1 infection

P. Massip, C. Pasquier, J. Puel, 2000, Journal of medical virology.

Lepromatous leprosy and seropositivity for HTLV-I.

G. Kaplanski, C. Tamalet, P. Disdier, 1990, American Journal of Medicine.

Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma.

C. Tamalet, A. Lafeuillade, C. Poggi, 1996, The Journal of infectious diseases.

Evaluation of type‐specific HPV persistence and high‐risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology

D. Olive, W. Prendiville, C. Tamalet, 2011, Journal of medical virology.

Impact of Tenofovir dose Adjustment on Both Estimated Glomerular Filtration Rate and Tenofovir trough Concentration

C. Solas, S. Brégigeon, C. Tamalet, 2017, Antiviral therapy.

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals

C. Charpentier, C. Delaugerre, J. Pawlotsky, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human papillomavirus type 7‐associated anal condyloma after renal transplantation in a child

P. Colson, C. Tamalet, M. Tsimaratos, 2019, Pediatric transplantation.

Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial

Eric Jullian, C. Tamalet, A. Lafeuillade, 2014, AIDS Research and Therapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Transmission of HIV-1 variants resistant to the three classes of antiretroviral agents: implications for HIV therapy in primary infection.

P. Colson, C. Tamalet, N. Yahi, 2002, AIDS.

Quantification of HIV‐1 proviral DNA by a standardized colorimetric PCR‐based assay

P. Massip, C. Pasquier, J. Puel, 1998, Journal of medical virology.

[In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].

C. Tamalet, T. Fosse, M. F. David, 1984, Pathologie et biologie.

Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy

D. Olive, C. Tamalet, J. Mancini, 2012, Journal of medical virology.

[Antibacterial activity of lamoxactam in combination with penicillin, ampicillin and amoxicillin against clinical strains of Enterococci, group B Streptococci and Listeria].

J. Duval, C. Tamalet, R. Leclercq, 1984, Pathologie-biologie.

Etravirine-raltegravir, a marked interaction in HIV-1-infected patients: about four cases.

C. Solas, S. Brégigeon, C. Tamalet, 2009, AIDS.

High level of HPV 16 and 18 DNA load in anal swabs from male and female HIV-1 infected patients.

C. Tamalet, I. Poizot-Martin, M. Henry, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Relationship between HPV 16, 18, 31, 33, 45 DNA detection and quantitation and E6/E7 mRNA detection among a series of cervical specimens with various degrees of histological lesions

H. Richet, C. Tamalet, M. Henry, 2015, Journal of medical virology.

Two years outcome of women infected with high risk HPV having normal colposcopy following low‐grade or equivocal cytological abnormalities: Are HPV16 and 18 viral load clinically useful predictive markers?

D. Olive, C. Tamalet, J. Mancini, 2012, Journal of medical virology.

Treatment of idiopathic chronic eosinophilic pneumonia with inhalation corticotherapy

C. Benaim, C. Tamalet, H. Gallais, 1989 .

Emergence of uncommon HIV‐1 non‐B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013‐2015 period in Marseille, Southeastern France

P. Brouqui, A. Stein, P. Colson, 2018, Journal of medical virology.

[HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhône].

C. Tamalet, H. Sancho-garnier, L. Piana, 2011, Bulletin du cancer.

Detection of rare hepatitis C viruses of subtype 4r in Southeastern France.

C. Tamalet, R. Gérolami, S. Aherfi, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Frequent transmission of hepatitis E virus among piglets in farms in Southern France

D. Raoult, P. Colson, M. Barthet, 2009, Journal of medical virology.

Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis.

J. Fantini, P. Colson, C. Tamalet, 1999, Journal of virological methods.

Factors Associated with Virological Response to Etravirine in Nonnucleoside Reverse Transcriptase Inhibitor-Experienced HIV-1-Infected Patients

V. Calvez, C. Charpentier, C. Delaugerre, 2009, Antimicrobial Agents and Chemotherapy.

Full-length title: Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection

D. Raoult, P. Colson, A. Levasseur, 2020, Scientific Reports.

Hepatitis C virus genotypes in Tirana, Albania.

P. Colson, C. Tamalet, Melpomeni Bizhga, 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Pilot phase I study using zidovudine in association with a 10‐day course of anti‐CD4 monoclonal antibody in seven AIDS patients

D. Olive, C. Dhiver, C. Tamalet, 1989, AIDS.

High viral burden in lymph nodes during early stages of HIV-1 infection.

P. de Micco, C. Tamalet, N. Yahi, 1993, AIDS (London).

Emergence of clusters of CRF02_AG and B human immunodeficiency viral strains among men having sex with men exhibiting HIV primary infection in southeastern France

H. Richet, P. Colson, S. Brégigeon, 2015, Journal of medical virology.

Isolation and quantification of HIV from lymph nodes.

C. Tamalet, 2005, Methods in molecular biology.

Secondary structure predictions of HIV-1 reverse transcriptase provide new insights into the development of drug-resistance genotypes.

J. Fantini, C. Tamalet, N. Yahi, 2001, AIDS.

Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase.

J. Fantini, C. Tamalet, N. Yahi, 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort

M. Ziol, C. Delaugerre, C. Katlama, 2020 .

Mutation L210W of HIV-1 Reverse Transcriptase in Patients Receiving Combination Therapy

J. Fantini, C. Tamalet, N. Yahi, 2000, Journal of Biomedical Science.

Comparison of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Mutations in HIV-1 Genomes Detected in Plasma and in Peripheral Blood Mononuclear Cells from Patients Receiving Combination Drug Therapy

J. Fantini, C. Tamalet, N. Yahi, 1999, Journal of Clinical Microbiology.

Severe transient neutropenia associated with acute human immunodeficiency virus type 1 infection.

P. Colson, C. Tamalet, C. Foucault, 2005, European journal of internal medicine.

Emerging Mutations and Associated Factors in Patients Displaying Treatment Failure on An Etravirine-Containing Regimen

V. Calvez, C. Delaugerre, B. Masquelier, 2012, Antiviral therapy.

Delayed HIV-1 seroconversion after antiretroviral therapy.

C. Apetrei, C. Tamalet, D. Descamps, 1998, AIDS.

Ledipasvir and Tenofovir drug interaction in HIV‐HCV co‐infected patients: Impact on Tenofovir Ctrough and Renal Safety

C. Solas, S. Brégigeon, C. Tamalet, 2017 .

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.

Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study.

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2020, The Journal of antimicrobial chemotherapy.

No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study.

C. Katlama, Y. Yazdanpanah, E. Delaporte, 2021, Journal of Antimicrobial Chemotherapy.

HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.

V. Calvez, C. Delaugerre, S. Yerly, 2008, The Journal of antimicrobial chemotherapy.

Vaginal self-sampling as a diagnosis tool in low-income countries and potential applications for exploring the infectious causes of miscarriage.

D. Raoult, C. Sokhna, C. Tamalet, 2017, Future microbiology.

Feasibility and Acceptability of Anal Self-Sampling for Human Papillomavirus Screening in HIV-Infected Patients

A. Stein, P. Colson, C. Dhiver, 2016, Intervirology.

Full-length title: Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection

D. Raoult, P. Colson, A. Levasseur, 2019, Scientific Reports.

Acute and chronic hepatitis E in patients infected with human immunodeficiency virus

C. Dhiver, C. Tamalet, R. Gérolami, 2011, Journal of viral hepatitis.

Hepatitis B and E Co-Primary Infections in an HIV-1-Infected Patient

P. Colson, C. Tamalet, H. Tissot-Dupont, 2013, Journal of Clinical Microbiology.

Reciprocal influence of HIV and HCV infections in co-infected patients and the involvement of HAART.

P. Colson, C. Tamalet, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.